Blue Ocean Capital Group
Shenzhenbocggp.com
Overview
Blue Ocean Capital Group is a life science-focused venture capital investment firm that invests in innovative biotech hubs in Greater China, the USA, and Northern Europe.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Signet Therapeutics | Jan 2026 | Series A | Co-investor |
| Innorna | Mar 2022 | Series B | Co-investor |
| Cure Genetics | Jan 2022 | Series B | Co-investor |
| Signet Therapeutics | Oct 2021 | Seed | Co-investor |
| Tapdata | Sep 2019 | Angel | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
